Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVectura Share News (VEC)

Share Price Information for Vectura (VEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.00
Bid: 112.40
Ask: 112.80
Change: -3.00 (-2.59%)
Spread: 0.40 (0.36%)
Open: 116.80
High: 117.00
Low: 109.80
Yest. Close: 116.00
VEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET OPEN: Tesco Leads Gains After Barclays Update

8 Jan 16 08:30

Vectura Group completes clinical trial, reveals US partner

(ShareCast News) - Vectura Group made a big step forward in the development of two of its products on Friday, VR315 and VR506, with the completion of a US clinical trial and the disclosure of its US development partner. The FTSE 250 firm described VR315 as a generic, inhaled combination therapy of f

8 Jan 16 07:47

Vectura Group Completes Clinical Trial For VR315 Asthma Treatment

8 Jan 16 07:29

Vectura Partner Ablynx Completes Enrolment For ALX-0171 Trial

18 Dec 15 14:10

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

15 Dec 15 09:46

Vectura Gets Milestone Payment As QVM149 Phase III Trial Begins

9 Dec 15 07:55

Vectura Loss Narrows On Better Royalty Income, Seebri Results Good

17 Nov 15 08:45

Higher royalties help lift Vectura interims

(ShareCast News) - Pharmaceutical group Vectura has posted a 57% rise in interim earnings before interest, tax, depreciation and amortisation to £4.7m driven by a 35% jump in revenues to £26.1m. Vectura, which specialises in products to treat airways-related diseases, trimmed its pre-tax losses to £

17 Nov 15 07:39

Earnings, Trading Statements Calendar - Week Ahead

10 Nov 15 16:01

LONDON MARKET CLOSE: Lower Close To Stellar October For Stocks

30 Oct 15 16:54

LONDON MARKET MIDDAY: IAG Falls After Guidance Disappoints Market

30 Oct 15 12:17

WINNERS & LOSERS SUMMARY: Investors Inhale Vectura Group Shares

30 Oct 15 10:26

LONDON MARKET OPEN: Stocks Mixed, IAG Drops Despite Guidance Upgraded

30 Oct 15 08:31

Vectura and Novartis win FDA approval for COPD combo

(ShareCast News) - Vectura and giant Swiss partner Novartis have received US drug regulator approval for their combination treatment for patients with chronic obstructive pulmonary disease (COPD), triggering a sizeable milestone payment for the UK company. The FTSE 250 drug developer and project par

30 Oct 15 08:09

Vectura Gets Two Milestone Payments From Novartis

30 Oct 15 07:43

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.